The optimal cut-off value of Ki-67 to guide the clinical management of patients with HCC remains undetermined, although previous studies have shown that high Ki-67 expression is associated with tumor differentiation, lymph node metastasis, and poor prognoses [6, 10]. This evidence concerns the gene MKI67 and hepatocellular carcinoma.